Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2371 (LINC02371)
- Target
- LINC02371
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Non-coding RNA, Other
01
Overview
Long intergenic non-protein coding RNA 2371 (LINC02371) is a human long non-coding RNA gene that produces a transcript classified as a lincRNA, meaning it is longer than 200 nucleotides and does not encode a protein[1][3][5]. LINC02371 is transcribed from a genomic region that does not overlap with known protein-coding genes[1][3]. While long intergenic non-coding RNAs are increasingly recognized for their potential roles in regulating gene expression and chromatin state through interactions with nucleic acids and proteins, LINC02371's specific biological function, disease relevance, and druggability have not been characterized in published sources[1][3][5]. As such, it is not considered a current therapeutic target nor has it been demonstrated as a biomarker or associated with safety issues. Research on lincRNAs as a class suggests they may serve regulatory functions and can be biomarkers in future studies[3][5].
- Other names
- LINC02371 (GeneCards, HGNC)Long intergenic non-protein coding RNA 2371
02
Biological functions
Regulation of gene expression (inferred for lincRNAs generally, not specific to LINC02371)Potential roles in cellular processes such as transcriptional regulation and chromatin organization (based on the general properties of lincRNAs)
03
Disease associations
Other (no direct evidence for involvement of LINC02371 in cancer, inflammation, neurodegeneration, or other diseases; however, some lincRNAs are markers or play regulatory roles in complex diseases)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2371 (LINC02371).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2371 (LINC02371).